Immunomedics, Inc.

Odeh v. Immunomedics, Inc., No. 2:18-cv-17645 (D. N.J.)

Stock ticker:

This lawsuit alleges that Defendants made materially false and misleading statements and omissions about Immunomedics' receipt of and approach to handling a Form 483 from the Food and Drug Administration, which ultimately caused the Company's new drug application to fail.

Block & Leviton is co-lead counsel with Robbins, Geller, Rudman & Dowd LLP in this litigation.

The Court denied Defendants’ Motion to Dismiss on July 31, 2020.

On January 20, 2023, Lead Plaintiffs moved the Court for preliminary approval of a $40 million settlement. Additional information will be provided here. A copy of the relevant preliminary approval papers are available on this page.

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.